SJSanjay Jaju

Sanjay Jaju

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sanjay Jaju has a total of 166 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long-term survival probability and predictors of mortality among adult patients living with HIV initiating combination antiretroviral therapy in Oman: an ambidirectional cohort study, 1992–2024

    by Zainab M. Al-Zadjali, Faryal Khamis, Amal Malehi, Sanjay Jaju, Sulaiman Dawood AlSabei, Ibtisam Khalifa Al-Maskari, Ruhina Aimaq, Jalila Al-Naamani, Kouthar Al-Alawi, Yahya M. Al-Farsi

    Acquired immunodeficiency syndrome (AIDS) remains a major global public health challenge despite substantial advances in combination antiretroviral therapy

  • Open Access

    Nonoptimal Virological Response Among Adults Living With HIV After Initiation of Combined Antiretroviral Therapy at a Tertiary Hospital in Oman: A Retrospective Cohort Study, 1992–2024

    by Zainab M. Al-Zadjali, Faryal Khamis, Sanjay Jaju, Amal Saki Malehi, Sulaiman Dawood Al Sabei, Ruhina Aimaq, Jalila Al-Naamani, Ibtisam Khalifa Al-Maskari, Zakariya Al-Balushi, Saif Al-Abri, et al.

    Background: Combined antiretroviral therapy (cART) has transformed HIV infection from a life‐threatening condition into a manageable chronic disease by reducing viral replication, preserving immune function, and lowering HIV‐related morbidity and mortality. Nevertheless, achieving and maintaining viral suppression remains an important challenge. Evidence regarding factors associated with nonoptimal virological response among people living with HIV in Oman remains limited. Aim: This study investigated factors associated with nonoptimal virological response among adults living with HIV who initiated cART and received follow‐up at the Royal Hospital, Oman, between 1992 and 2024. Methods: A retrospective cohort study was undertaken at the Royal Hospital, Muscat, Oman, the national tertiary referral center for HIV care. The analysis included 549 adults aged ≥ 18 years who initiated cART and had the laboratory and clinical information required for the study. Participants were eligible if they had two consecutive HIV RNA measurements, both obtained at least 6 months after cART initiation. Optimal viral suppression was defined as HIV RNA ≤ 20 copies/mL, whereas nonoptimal virological response was classified only when both consecutive HIV RNA measurements were > 20 copies/mL, based on the laboratory and clinical monitoring threshold used at the Royal Hospital and Ministry of Health guidance. Participants with only one eligible measurement or discordant measurements were not classified as having a nonoptimal virological response. Clinical information was retrospectively retrieved from electronic medical records. Data were analyzed using IBM SPSS Statistics Version 28. Multivariable Poisson regression with robust variance was used to estimate adjusted risk ratios (aRRs) and corresponding 95% confidence intervals (CIs). Statistical significance was considered at p ≤ 0.05. Results: Of the 549 participants, 321 (58.5%) had HIV RNA ≤ 20 copies/mL and 228 (41.5%) had HIV RNA > 20 copies/mL. Compared with individuals diagnosed in 2020 or later, the risk of nonoptimal virological response was higher among those diagnosed in 2008 or earlier (aRR: 2.166, 95% CI: 1.160–4.043) and those diagnosed between 2009 and 2014 (aRR: 2.273, 95% CI: 1.258–4.107). Male participants had a higher risk than female (aRR: 2.154, 95% CI: 1.172–3.960). Diagnosis through antenatal care was also associated with nonoptimal virological response (aRR: 3.662, 95% CI: 1.263–10.618), although the estimate should be interpreted cautiously because of the small number of participants in this category. WHO clinical Stage 3 was associated with a lower estimated risk compared with Stage 4, although the association was not statistically significant (aRR: 0.592, 95% CI: 0.349–1.005; p = 0.052). Participants with hemoglobin levels ≤ 10 g/dL also had an increased risk of nonoptimal virological response (aRR: 1.676, 95% CI: 1.020–2.753). Conclusion: Five sociodemographic and clinical factors were independently associated with detectable HIV RNA among adults receiving cART in Oman: sex, period of HIV diagnosis, antenatal testing, WHO clinical stage, and hemoglobin concentration. These findings support continued efforts to identify patients who may require closer clinical monitoring and individualized support to achieve and maintain viral suppression.

  • Open Access

    Clinical Characteristics and Risk factors of Acute Pancreatitis in Paediatric Patients in Oman: An 11-year experience from a tertiary centre

    by Shurooq S. Al Shereiqi, Aisha Al Fudhaili, Dafalla Rahmatalla, Ravi Chandra, Sanjay Jaju, Ahmed Al Adawi, Adawiya Al Jamei, Yusriya Al Rawahi

    Objectives: The incidence of acute pancreatitis (AP) in the paediatric population has increased over the past two decades, with an estimated annual rate of 0.78 per 100,000 children. This study aimed to describe the risk factors and characteristics of AP in Omani children. Methods: A retrospective cohort study was conducted, including all children <14 years who were admitted and treated with AP at Sultan Qaboos University Hospital in Muscat, Oman, from January 2010 to December 2020. Case presentations, aetiology, management, and outcomes were reviewed. Results: During the 11-year study period, 55 cases were identified (male: female, 1.2:1). The most frequently reported risk factors were toxic/metabolic (49.1%). Abdominal pain was the predominant symptom (76.4%). Conservative treatment was administered in 74.5% of cases, while the remaining patients required surgery or endoscopic retrograde cholangiopancreatography. Of the 55 patients, 51 fully recovered. The number of risk factors per case was not associated with patient outcomes or length of hospital stay. Conclusion: Future multicentre and prospective studies with comprehensive data collection are crucial to further understand paediatric AP in Oman and inform potential modifications to treatment guidelines.

  • Prevalence of adverse childhood experiences in Oman

    by Zeinab Al Azri, Aziza Alsawafi, Sanjay Jaju, Mohammad Al Qadire

  • Open Access

    Radiological Study of the Normal and Anatomical Variants of the Celiac Trunk and Its Branches: Clinical Implications

    by Ali Abduwani, Ilyas Al-Saadi, Mohammed Al-Hajri, Saleh Baawain, Mahmood Salim Nasser Al Riyami, Naseer Al Sidairi, Al Khatab Abdullah Saud Isma’ili, Sanjay Jaju, Srijit Das

    The abdominal aorta enters the diaphragm at the level of the 12th thoracic vertebra and gives branches such as the celiac trunk (CT), superior mesenteric, and inferior mesenteric arteries. The main aim of the present research study was to observe the CT with regard to (i) variations in the dimensions among different age groups compared to gender, (ii) the vertebral level of origin, and (iii) the variation in the branching pattern. This cross-sectional retrospective study was performed on 116 subjects (n = 91 males, n = 25 females) over one year. The CT was interpreted by using contrast-enhanced computed tomography angiography. The results were assessed using parametric and non-parametric statistical tests. The length and diameter between gender and the three age groups (i.e., 29 years and below, 30–39 years, and more than 40 years) were compared and a p-value of less than or equal to 0.05 was considered significant. There was a significant difference in the length (p = 0.016) and diameter of the CT (p = 0.05) among males and females, respectively. Moreover, there was a significant difference in the length (p = 0.038) and diameter (p = 0.013) of the CT among the three age groups. Individuals aged 30–39 years had the highest mean for the length of the CT, while patients aged 29 years and younger had the highest diameter. The most common level for CT origin was at the vertebral level of the 12th thoracic vertebra (73.3%). Anatomical knowledge of the CT is important for diagnostic imaging, organ transplantations, and surgical and laparoscopic interventions.


  • Open Access

    Antimicrobial Susceptibility of Uropathogenic Escherichia coli with Analysis of Impact of Socio-Economic Factors in Low, Medium and High-Income Countries

    by Meher Rizvi, Maria Khan, Amina AL Jardani, Ujjala Ghoshal, Zaaima AL Jabri, Mohammad Ahanjan, Azza AL Mamari, Nawal AL Shizawi, Hiba Sami, Abdullah Balkhair, et al.

    Background: While mapping Escherichia coli susceptibility in community acquired simple UTIs across 38 centres, DASH to Protect Antibiotics, (https://dashuti.com/), a multiregional study also assessed impact of socio-economic conditions and climate on antimicrobial susceptibility. Methods: The centres were located in the Indian subcontinent, Middle East, North and West Africa, Eurasia, Europe, and North America. Harmonic means were used for comparative analysis of the antimicrobial susceptibility of E. coli in simple cystitis. Kruskal-Wallis test was utilized to compare susceptibility means between the antimicrobials and the GDP. A two-way ANOVA to simultaneously analyzed the impact of the antimicrobials and GDP on the proportion of susceptible E. coli while adjusting for variables (low and high temperature, humidity and population density per sqkm). Findings: Antimicrobial susceptibility varied between regions and within large countries like India and Pakistan. Nitrofurantoin (89%) and fosfomycin (96%) emerged as the most effective antimicrobials. In majority of the centres, susceptibility to other oral antimicrobials was low: cotrimoxazole.


  • Open Access

    Adverse childhood experiences and risky behaviors in Oman: A cross-sectional study

    by Zeinab Al Azri, Khalood Al-Abri, Aziza Al Sawafi, Sanjay Jaju, Mohammad Al Qadire


  • Open Access

    Association of the Magnitude of Anti-SARS-CoV-2 Vaccine Side Effects with Sex, Allergy History, Chronic Diseases, Medication Intake, and SARS-CoV-2 Infection

    by Elias A. Said, Afnan Al-Rubkhi, Sanjay Jaju, Crystal Y. Koh, Mohammed S. Al-Balushi, Khalid Al-Naamani, Siham Al-Sinani, Juma Z. Al-Busaidi, Ali A. Al-Jabri

    Vaccination provides the best protection against the increasing infections of SARS-CoV-2. The magnitude and type of anti-SARS-CoV-2 vaccine side effects (SEs) depend on parameters that are not fully understood. In this cross-sectional study, the associations between different anti-SARS-CoV-2 vaccine SEs and age, sex, the presence of chronic diseases, medication intake, history of allergies, and infections with SARS-CoV-2 were investigated. Our survey used the Google platform and had 866 participants, contacted through e-mails, social media and chain referral sampling (margin of error ≈ 4.38%, 99% confidence). More than 99% of the participants received the BNT162b2 and ChAdOx1-S vaccines. Being female, having chronic diseases, taking medicines routinely and the presence of a SARS-CoV-2 infection (p < 0.05) were associated with strong SEs after the BNT162b2 vaccine second dose. Having a history of allergies and a female sex (p < 0.01) were associated with strong SEs after the ChAdOx1-S vaccine second dose. Furthermore, the results reveal, for the first time, the associations between having a history of allergies, chronic diseases, medication usage, and SEs of a strong magnitude for the BNT162b2 and ChAdOx1-S vaccines. Additionally, this study supports the association of the female sex and infection with SARS-CoV-2 with an increased potential of developing stronger SEs with certain anti-SARS-CoV-2 vaccines.


  • Open Access

    Effects of a Healthy Diet on Reducing Symptoms of Premenstrual Syndrome and Improving Quality of Life among Omani Adolescents: A Randomized Controlled Open-Label Trial

    by Maisa Hamed Al Kiyumi, Zalikha Al Belushi, Amal Al Amri, Rawan Al Musharrafi, Fathiya Al Rashdi, Sanjay Jaju, Asma Al Shidhani, Abdulaziz Al Mahrezi

    Premenstrual syndrome (PMS) continues to impact the health outcomes and emotional well-being of reproductive-age women, globally. Several studies have provided conflicting evidence concerning the role of dietary approaches in improving PMS symptoms. Accordingly, this study aimed to evaluate the possible influence of a healthy diet and motivational strategies on PMS symptoms and health-related quality of life among Omani adolescents. This open-label, randomized, prospective controlled trial was conducted at two randomly selected secondary schools, in Al Seeb Willayah, in Muscat region. Adolescents with PMS symptoms, who were in grade 10 or 11, aged 16 years or above, had regular menstrual cycles, and were not known to have psychiatric disorder were included in this study. Participants in the intervention group received an individual face-to-face dietary consultation and motivational phone consultation. The health outcomes, including the PMS symptoms in both groups, and quality of life, were recorded using the Daily Record of Severity of Problems questionnaire (DRSP) and the 14-item Self-Reporting-Based Perceived Stress Scale tools, respectively. The primary outcome was the difference in the mean premenstrual symptom scores between the two groups. Secondary outcomes included the quality of life and stress levels of participants. The study period was from 1 February and ended 30 June 2021. SPSS was used to analyze the data, and intention-to-treat analysis was utilized. A total of 72 adolescents with PMS were randomized into intervention and control groups (n = 36 each). Both groups were similar at baseline (p-value > 0.05). No significant association was found between a healthy diet and PMS symptoms (p-value > 0.05). In addition, no significant association was found between a healthy diet and quality of life at follow-up (p-value = 0.216). The outcomes of this study refuted any possible relationships between a healthy diet and PMS symptoms. Accordingly, dietary consultations may not facilitate the clinical management of PMS symptoms in adolescent females.


  • Open Access

    The Practice of Prescribing Antidepressants During Pregnancy and Breastfeeding Among Mental Health Practitioners in Tertiary Care Centers in Oman

    by Salim Al Kasbi, Yousif Obaid, Samir Al Adawi, Sanjay Jaju

    Objectives: This study sought to determine the confidence level of mental health practitioners in Oman regarding the use of antidepressants during pregnancy and breastfeeding, assess their knowledge and need for further training in this area, and examine their current prescribing patterns and preferences. Methods: A questionnaire-based survey was conducted from May to June 2017 among all practitioners in the psychiatry specialty, including medical officers authorized to prescribe medications, at the Behavioral Medicine Department of Sultan Qaboos University Hospital and Al Masarra Hospital. Results: Forty-two practitioners (response rate = 89.4%) responded to the questionnaire. Of them, 10 (23.8%) had no experience, while 30 (71.4%) had experience in prescribing antidepressants during both pregnancy and breastfeeding periods. Twenty-seven (64.3%) respondents felt that they were confident in prescribing antidepressants for women during their perinatal period, while 30.0% were neutral. Moreover, 35 (83.3%) participants expressed the need for more training in this area. Furthermore, 34 (81.0%) believed that more training in perinatal psychiatry should be included in the psychiatry curriculum. There was no consistent prescribing pattern (either prescribing or avoiding) among our participating practitioners during the first trimester of pregnancy and breastfeeding periods. The drug of choice in the first trimester of pregnancy was fluoxetine preferred by approximately 85.0% of the practitioners, but avoided by 10.0% of practitioners in the same period. This was followed by amitriptyline (50.0% vs. 23.0%), sertraline (50.0% vs. 9.0%), imipramine (28.0% vs. 84.0%). During breastfeeding, the drug of choice for approximately 74.0% of the practitioners was paroxetine, but avoided by 15.0% of practitioners. This was followed by sertraline (50.0% vs. 8.0%). The most common reasons for prescription during pregnancy were safety, evidence-based practice, and low teratogenicity. For breastfeeding, the main reasons for prescription were low levels of the drug in breast milk, safety, and evidence-based practice. On the other hand, high teratogenicity, neonatal side effects, limited data, and lack of evidence were among the most common reasons behind avoiding prescribing during pregnancy, while high levels of breast milk, neonatal side effects, limited evidence, and safety concerns were the most common reasons during the breastfeeding period. Conclusions: There was inconsistency among mental health practitioners in making prescription decisions and in their prescribing patterns.